Drug:
Reaction: HAEMORRHAGE
20250101 - 20251231
No. 101 - 200
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
101 | 25136042 |
US |
15 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
102 | 25136709 |
US |
2 | |
Pneumonia, COVID-19, Haemorrhage, Influenza, Product use issue, |
||||
APIXABAN, METOPROLOL TARTRATE, METOPROLOL, INSULIN GLARGINE, DEXMEDETOMIDINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, LEVETIRACETAM, METHYLPREDNISOLONE SODIUM SUCCINATE, ERGOCALCIFEROL, GUAIFENESIN, LEVOTHYROXINE SODIUM, SPIRONOLACTONE, MAGNESIUM, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, |
||||
103 | 25136996 |
GB |
2 | |
Illness, Haemorrhage, |
||||
TIRZEPATIDE, |
||||
104 | 25137035 |
US |
38 | 1 |
Haemorrhage, |
||||
ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC-VWF-XTEN FUSION PROTEIN-EHTL, |
||||
105 | 25137036 |
US |
19 | 1 |
Haemorrhage, |
||||
ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC-VWF-XTEN FUSION PROTEIN-EHTL, |
||||
106 | 25137064 |
US |
1 | |
Colostomy, Haemorrhage, Hepatic enzyme increased, |
||||
UPADACITINIB, |
||||
107 | 25137124 |
UY |
16 | 2 |
Retinal artery occlusion, Acne, Faecal calprotectin decreased, Haemorrhage, Rash, Fear, |
||||
UPADACITINIB, UPADACITINIB, |
||||
108 | 25126470 |
US |
59 | 1 |
Haemorrhage, |
||||
INSULIN GLARGINE, |
||||
109 | 25126476 |
US |
57 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
110 | 25126911 |
US |
82 | 1 |
Haemorrhage, Off label use, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
111 | 25127290 |
GR |
||
Drug-induced liver injury, Off label use, Bacterial infection, Deep vein thrombosis, Acute kidney injury, Acute coronary syndrome, Haemorrhage, Arrhythmia, |
||||
TOCILIZUMAB, BARICITINIB, |
||||
112 | 25127374 |
US |
24 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
113 | 25127771 |
US |
31 | 2 |
Laparotomy, Haemorrhage, Device breakage, Foreign body in reproductive tract, Complication of device removal, Pelvic inflammatory disease, Ovarian abscess, Emotional disorder, Cystitis, Pain, Abnormal uterine bleeding, |
||||
COPPER, |
||||
114 | 25127969 |
CN |
67 | 2 |
Altered state of consciousness, Subdural haematoma, Intracranial mass, Haemorrhage, Condition aggravated, |
||||
CLOPIDOGREL BISULFATE, |
||||
115 | 25128009 |
US |
60 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
116 | 25128656 |
US |
50 | 1 |
Haemorrhage, |
||||
117 | 25128658 |
US |
46 | 1 |
Haemorrhage, Pain, |
||||
118 | 25128822 |
BR |
||
Haemorrhage, Drug ineffective, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
119 | 25129027 |
US |
75 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
120 | 25129306 |
US |
1 | |
Haemorrhage, Tooth disorder, |
||||
EMICIZUMAB, |
||||
121 | 25129337 |
US |
55 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
122 | 25129340 |
US |
32 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
123 | 25129399 |
US |
||
Acute hepatic failure, Toxicity to various agents, Arrhythmia, Infection, Septic shock, Gastrointestinal haemorrhage, Haemorrhage, Brain oedema, Seizure, Acute respiratory distress syndrome, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
124 | 25129528 |
US |
||
Acute hepatic failure, Toxicity to various agents, Arrhythmia, Infection, Septic shock, Gastrointestinal haemorrhage, Haemorrhage, Brain oedema, Seizure, Acute respiratory distress syndrome, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
125 | 25129802 |
VN |
3 | |
Haemorrhage, |
||||
EMICIZUMAB, |
||||
126 | 25129885 |
US |
22 | 2 |
Psoriasis, Haemorrhage, Drug ineffective, |
||||
INFLIXIMAB, |
||||
127 | 25129952 |
US |
1 | 1 |
Haemorrhage, Head injury, Fall, |
||||
128 | 25130161 |
US |
35 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN HUMAN, |
||||
129 | 25130216 |
CA |
72 | 1 |
Airway remodelling, Microangiopathy, Chronic sinusitis, Ventricular hypokinesia, Memory impairment, Eosinophil count increased, Eosinophilic granulomatosis with polyangiitis, Lymphopenia, Respiratory symptom, Hypertension, Central nervous system mass, Cardiac septal defect, Pneumonia, Respiratory tract infection, Nasal polyps, Atopy, Prostate cancer, Haemorrhage, Eosinophilic myocarditis, Asthma, Eosinophil count decreased, Obesity, Nodule, Haematuria, Confusional state, Blood immunoglobulin E increased, Obstructive airways disorder, Wall motion score index abnormal, Renal disorder, Productive cough, Eosinophilic pneumonia, Viral infection, Lacrimation increased, Condition aggravated, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, CALCIUM, ALBUTEROL SULFATE, ALENDRONATE SODIUM, FOLIC ACID, LANSOPRAZOLE, BEVACIZUMAB, BEVACIZUMAB, BICALUTAMIDE, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, RAMIPRIL, CICLESONIDE, GOSERELIN, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
130 | 25130434 |
US |
56 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
131 | 25130701 |
US |
72 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
132 | 25131037 |
CA |
33 | 2 |
Abdominal pain, Alopecia, Anorectal disorder, Anxiety, Arthralgia, Attention deficit hyperactivity disorder, Brain fog, Breast pain, Burning sensation, Chills, Cognitive disorder, Drug ineffective, Drug interaction, Dyspepsia, Dysphagia, Dyspnoea, Gastrointestinal pain, Haemorrhage, Headache, Hepatic pain, Hyperhidrosis, Joint swelling, Pain, Paraesthesia, Peripheral swelling, Photosensitivity reaction, Product availability issue, Product formulation issue, Product physical issue, Product shape issue, Product size issue, Product substitution issue, Suspected product tampering, Product taste abnormal, Rash, Rash erythematous, Swelling, Temperature regulation disorder, Therapy interrupted, Tremor, Urinary tract pain, Vaginal disorder, Withdrawal syndrome, |
||||
NIRMATRELVIR AND RITONAVIR, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, AMITRIPTYLINE HYDROCHLORIDE, LISDEXAMFETAMINE DIMESYLATE, |
||||
133 | 25131063 |
US |
67 | 2 |
Contusion, Haemorrhage, |
||||
INSULIN LISPRO, INSULIN DETEMIR, |
||||
134 | 25131252 |
US |
78 | 2 |
Discomfort, Haemorrhage, Pain, |
||||
INSULIN LISPRO, INSULIN DEGLUDEC, |
||||
135 | 25131253 |
US |
74 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
136 | 25131307 |
US |
73 | 2 |
Haemorrhage, |
||||
INSULIN GLARGINE, HUMAN INSULIN, |
||||
137 | 25131309 |
US |
51 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
138 | 25131380 |
US |
29 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
139 | 25131462 |
CN |
1 | |
Haemorrhage, |
||||
140 | 25131519 |
FR |
77 | 2 |
Confusional state, Agitation, Hallucination, Somnolence, Aggression, Hypokalaemia, Hypophosphataemia, Persecutory delusion, Haemorrhage, Choking, Pulmonary congestion, Head injury, Fall, Encephalopathy, Clostridium difficile colitis, |
||||
METHYLPREDNISOLONE, OLANZAPINE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, OXAZEPAM, OXAZEPAM, METHADONE HYDROCHLORIDE, METHADONE, METHADONE HYDROCHLORIDE, METHADONE, MORPHINE SULFATE, APIXABAN, IRBESARTAN, NALOXEGOL OXALATE, LANSOPRAZOLE, AMLODIPINE, HYDROCHLOROTHIAZIDE, LEVOTHYROXINE, BEVACIZUMAB, FLUOROURACIL, FLUOROURACIL, OXALIPLATIN, |
||||
141 | 25131560 |
US |
80 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
142 | 25131579 |
US |
57 | 2 |
Haemorrhage, |
||||
INSULIN GLARGINE, |
||||
143 | 25131608 |
US |
76 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
144 | 25131663 |
US |
81 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
145 | 25131685 |
US |
69 | 1 |
Haemorrhage, |
||||
INSULIN GLARGINE, |
||||
146 | 25131860 |
US |
||
Hypoxia, Arrhythmia, Abdominal pain, Anaemia, Pleural effusion, Hypotension, Dizziness, Dyspnoea, Microcytic anaemia, Gastrooesophageal reflux disease, Haemorrhage, |
||||
SELEXIPAG, SELEXIPAG, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, AMBRISENTAN, CEPHALEXIN, TRIMETHOPRIM, WARFARIN, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
147 | 25131889 |
US |
61 | 1 |
Condition aggravated, Myalgia, Haemorrhage, |
||||
SECUKINUMAB, |
||||
148 | 25134229 |
1 | ||
Haemorrhage, |
||||
DAROLUTAMIDE, |
||||
149 | 25121620 |
AU |
63 | 1 |
Haematemesis, Pharyngeal ulceration, Pharyngo-oesophageal diverticulum, Haemorrhage, Epistaxis, Haemoptysis, |
||||
CLOPIDOGREL, CLOPIDOGREL BISULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
150 | 25121795 |
US |
52 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
151 | 25121932 |
US |
29 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
152 | 25122044 |
US |
77 | 2 |
Haemorrhage, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TADALAFIL, AMBRISENTAN, |
||||
153 | 25122052 |
US |
29 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
154 | 25122059 |
US |
57 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
155 | 25122093 |
US |
62 | 1 |
Autoimmune arthritis, Adrenal insufficiency, Quadriparesis, Pneumonia parainfluenzae viral, Rib fracture, COVID-19, Intestinal obstruction, Respiratory distress, COVID-19 pneumonia, Neurogenic bowel, Autonomic neuropathy, Impaired gastric emptying, Anaphylactic reaction, Sepsis, Hydronephrosis, Apnoea, Sternal fracture, Adrenocortical insufficiency acute, Pituitary-dependent Cushing^s syndrome, Hypopituitarism, Hypersensitivity, Kyphosis, Diastasis recti abdominis, Upper respiratory tract infection, Upper respiratory tract infection, Bronchitis, Vaccination site pain, Vaccination site erythema, Vaccination site swelling, Chills, Pyrexia, Herpes zoster, Testicular disorder, Abdominal hernia, Lymphadenopathy, Ecchymosis, Haemorrhage, Vitiligo, Heat stroke, Keratoacanthoma, Tooth fracture, Benign prostatic hyperplasia, Drug hypersensitivity, Fatigue, Arthralgia, Myalgia, Wisdom teeth removal, Gait disturbance, Arthralgia, Folate deficiency, Drug ineffective, Compression fracture, Gastrointestinal microorganism overgrowth, Osteoporosis, Asthma, Lower urinary tract symptoms, |
||||
ALENDRONATE SODIUM, PREDNISONE, PEMBROLIZUMAB, ADALIMUMAB, ADALIMUMAB, METHOTREXATE, METHOTREXATE SODIUM, ETANERCEPT, IBUPROFEN, IBUPROFEN AND DIPHENHYDRAMINE CITRATE, GOLIMUMAB, INFLIXIMAB, |
||||
156 | 25122129 |
US |
67 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN DEGLUDEC, |
||||
157 | 25122350 |
US |
70 | 2 |
Haemorrhage, |
||||
INSULIN GLARGINE, |
||||
158 | 25122546 |
US |
||
Haemorrhage, Cerebrovascular accident, |
||||
VORASIDENIB, BEVACIZUMAB, |
||||
159 | 25122982 |
US |
||
Haemorrhage, |
||||
RELUGOLIX, RELUGOLIX, TALAZOPARIB, |
||||
160 | 25123159 |
US |
47 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, SEMAGLUTIDE, INSULIN GLARGINE, |
||||
161 | 25123440 |
US |
45 | 1 |
Haemorrhage, |
||||
162 | 25123609 |
US |
60 | 1 |
Haemorrhage, Discomfort, Pain, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
163 | 25124172 |
CA |
||
Drug interaction, Contraindicated product administered, Haemorrhage, |
||||
NIRMATRELVIR AND RITONAVIR, RIVAROXABAN, |
||||
164 | 25124356 |
US |
33 | 2 |
Haemorrhage, Haematochezia, Dyspnoea, Blood urine present, Dehydration, Fatigue, Gastrointestinal disorder, |
||||
FRUQUINTINIB, |
||||
165 | 25124687 |
CA |
2 | |
Haematochezia, Pregnancy, Haemorrhage, Exposure via breast milk, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, VEDOLIZUMAB, PREDNISONE, |
||||
166 | 25124720 |
50 | 2 | |
Haemorrhage, Thrombosis, |
||||
LEUPROLIDE ACETATE, |
||||
167 | 25125420 |
ES |
||
Death, Renal failure, Haemorrhage, Drug intolerance, Infection, |
||||
IBRUTINIB, |
||||
168 | 25125867 |
US |
42 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN DEGLUDEC, |
||||
169 | 25126092 |
US |
85 | 2 |
Melaena, Cardiac disorder, Haemorrhage, |
||||
APIXABAN, TAFAMIDIS, |
||||
170 | 25126134 |
JP |
||
Gastric cancer, Intra-abdominal haematoma, Abdominal pain, Haemorrhage, |
||||
CLOPIDOGREL, CLOPIDOGREL, |
||||
171 | 25115793 |
US |
46 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, TIRZEPATIDE, INSULIN DEGLUDEC, |
||||
172 | 25115898 |
US |
17 | 1 |
Haemorrhage, |
||||
EMICIZUMAB, EMICIZUMAB, |
||||
173 | 25115996 |
GB |
29 | 2 |
Dysmenorrhoea, Haemorrhage, |
||||
DAPAGLIFLOZIN, DAPAGLIFLOZIN, LOSARTAN, DAPAGLIFLOZIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
174 | 25116105 |
US |
78 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
175 | 25116128 |
US |
60 | 2 |
Haemorrhage, |
||||
INSULIN GLARGINE, INSULIN LISPRO, |
||||
176 | 25116432 |
US |
44 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
177 | 25116449 |
US |
2 | |
Multiple sclerosis, Fall, Haemorrhage, Scar, Psychiatric symptom, Memory impairment, Pigmentation disorder, Ill-defined disorder, |
||||
OFATUMUMAB, |
||||
178 | 25116579 |
US |
11 | 2 |
Haemorrhage, Fall, |
||||
INSULIN LISPRO, |
||||
179 | 25116625 |
US |
||
Haemorrhage, Off label use, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, EMICIZUMAB, EMICIZUMAB, |
||||
180 | 25116779 |
US |
65 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
181 | 25116784 |
US |
27 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
182 | 25116786 |
US |
63 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
183 | 25116952 |
US |
1 | |
Pleural mesothelioma, Exposure to chemical pollution, Shock, Haemorrhage, Pulmonary necrosis, Sepsis, |
||||
184 | 25117056 |
US |
52 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN ASPART, |
||||
185 | 25117057 |
US |
81 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
186 | 25117066 |
US |
54 | 2 |
Haemorrhage, Skin reaction, |
||||
INSULIN LISPRO, |
||||
187 | 25117345 |
US |
89 | |
Haemorrhage, Off label use, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, RITUXIMAB, RITUXIMAB, EMICIZUMAB, |
||||
188 | 25117457 |
US |
25 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
189 | 25117465 |
US |
87 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
190 | 25117473 |
US |
63 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
191 | 25117897 |
US |
51 | 1 |
Haemorrhage, Haemarthrosis, |
||||
192 | 25117973 |
US |
55 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
193 | 25117977 |
US |
72 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
194 | 25118422 |
GR |
39 | 1 |
Immune thrombocytopenia, Thrombocytopenia, Haemorrhage, |
||||
ALEMTUZUMAB, ALEMTUZUMAB, |
||||
195 | 25118576 |
US |
||
Bronchiectasis, Pulmonary haemorrhage, Bacterial infection, Chronic obstructive pulmonary disease, Wheezing, Therapy cessation, Dyspnoea, Breath odour, Epistaxis, Inflammation, Haemorrhage, Dysphonia, Speech disorder, Amnesia, Asthma, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
196 | 25118830 |
GR |
48 | 1 |
Immune thrombocytopenia, Haemorrhage, |
||||
ALEMTUZUMAB, ALEMTUZUMAB, |
||||
197 | 25119981 |
IT |
||
Death, Glioblastoma, Embolism venous, Embolism arterial, Off label use, Hypertension, Haemorrhage, Proteinuria, Therapeutic product effect incomplete, |
||||
BEVACIZUMAB, |
||||
198 | 25120553 |
US |
2 | |
Renal disorder, Urinary tract infection, Full blood count decreased, Vitamin K decreased, Haemorrhage, |
||||
ADALIMUMAB, |
||||
199 | 25120621 |
IT |
||
Thyroid disorder, Skin reaction, Pruritus, Alanine aminotransferase increased, Aspartate aminotransferase increased, Arthritis, Colitis, Nephritis, Proteinuria, Hypertension, Stomatitis, Thrombosis, Gastrointestinal haemorrhage, Haemorrhage, Fatigue, Decreased appetite, Diarrhoea, Neuropathy peripheral, Neoplasm progression, |
||||
ATEZOLIZUMAB, BEVACIZUMAB, |
||||
200 | 25120682 |
GB |
61 | 2 |
Gastrointestinal haemorrhage, Anal haemorrhage, Haematochezia, Haemorrhage, |
||||
TIRZEPATIDE, |
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28